SNWV SANUWAVE Health, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1417663 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.1%
TTM net income YoY128.0%
TTM EPS YoY76.9%
Revenue 3-yr CAGR29.5%
Net income 3-yr CAGR—
Margins
Gross margin76.0%
Operating margin-4.5%
Net margin6.3%
FCF margin6.3%
EBITDA margin-1.7%
Returns
ROE—
ROA7.6%
ROIC (approx.)-124.0%
Asset turnover1.20x
Leverage & solvency
Liabilities / assets91.2%
Debt / equity0.00x
Current ratio1.18x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.28x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $44.05M | $32.63M | $20.40M | $16.74M | $13.01M |
| Cost of revenue | $10.08M | $8.08M | $6.04M | $4.33M | $4.99M |
| Gross profit | $33.97M | $24.55M | $14.36M | $12.41M | $8.02M |
| R&D expense | $1.35M | $673,000 | $579,000 | $567,000 | $1.10M |
| SG&A expense | $19.37M | $12.92M | $8.67M | $12.56M | $11.69M |
| Operating income | $4.95M | $3.85M | -$540,000 | -$8.95M | -$14.14M |
| Interest expense | — | $12.56M | — | $12.77M | $6.88M |
| Pretax income | $11.90M | -$33.06M | -$25.78M | -$10.28M | -$27.21M |
| Income tax | $86,000 | $27,000 | $4,000 | $2,000 | $28,000 |
| Net income | $11.81M | -$33.08M | -$25.81M | -$10.29M | -$27.26M |
| EBITDA | $5.92M | $4.64M | $488,000 | -$8.00M | -$12.91M |
| EPS (basic) | 1.38 | -7.41 | -12.19 | -0.02 | -0.05 |
| EPS (diluted) | 0.41 | -7.41 | -12.19 | -0.02 | -0.05 |
| Weighted avg. shares (diluted) | 9.08M | 4.46M | 2.12M | 549.47M | 518.36M |
| Balance sheet | |||||
| Cash & equivalents | $11.96M | $10.24M | $1.80M | $1.15M | $619,000 |
| Receivables | $5.42M | $3.33M | $3.31M | $4.03M | $2.42M |
| Inventory | $5.93M | $4.15M | $2.95M | $868,000 | $1.04M |
| Current assets | $24.63M | $18.40M | $9.78M | $6.62M | $4.40M |
| PP&E, net | $1.97M | $303,000 | $938,000 | $856,000 | $1.01M |
| Goodwill | $7.26M | $7.26M | $7.26M | $7.26M | $7.26M |
| Intangibles | $3.03M | $3.73M | $4.43M | $5.14M | $5.84M |
| Total assets | $37.34M | $30.12M | $22.42M | $19.87M | $18.62M |
| Current liabilities | $17.85M | $45.42M | $64.75M | $60.22M | $56.26M |
| Short-term debt | $5.75M | — | — | — | $25.39M |
| Long-term debt | $16.14M | — | — | — | $875,000 |
| Total debt | $21.89M | — | — | — | $26.26M |
| Total liabilities | $35.72M | $45.91M | $65.59M | $60.88M | $57.58M |
| Shareholders' equity | $1.62M | -$15.79M | -$44.55M | -$41.01M | -$38.96M |
| Net debt | $9.93M | — | — | — | $25.64M |
| Shares outstanding | 8.59M | 8.54M | 3.04M | 548.74M | 481.62M |
| Cash flow statement | |||||
| Operating cash flow | $3.88M | $2.46M | -$4.54M | -$17.17M | -$6.41M |
| Capital expenditure | $1.94M | $490,000 | $0 | — | $529,000 |
| Free cash flow | $1.93M | $1.97M | -$4.54M | — | -$6.94M |
| Investing cash flow | $3.43M | -$490,000 | $21,000 | $332,000 | -$529,000 |
| Financing cash flow | -$5.59M | $6.35M | $5.21M | $17.38M | $5.12M |
| Depreciation & amortization | $974,000 | $788,000 | $1.03M | $952,000 | $1.24M |
| Stock-based compensation | $4.85M | $1.51M | $0 | — | $0 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.